Guizhou ChitianhuaLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Lin Hong Ding

Chief executive officer

CN¥815.7k

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	2.7yrs

Recent management updates

Recent updates

CEO

Lin Hong Ding (58 yo)

no data

Tenure

CN¥815,700

Compensation

Mr. Lin Hong Ding has been Chairman of the Board of Directors of Guizhou Salvage Pharmaceutical Co.,Ltd. since November, 2014 and serves as its General Manager. He has been Chairman of the Board of Directo...

Board Members

Name	Position	Tenure	Compensation	Ownership
Lin Hong Ding	Chairman & GM	no data	CN¥815.70k	no data
Min Hong Gao	Executive Deputy GM & Director	no data	CN¥752.80k	0.0088% CN¥ 353.8k
Hongyan Wu	Deputy GM & Director	2.9yrs	CN¥702.80k	0.0047% CN¥ 189.6k
Lin Hui Ding	Director	no data	CN¥100.00k	no data
Qi Yong Fan	Independent Director	2.7yrs	CN¥150.00k	no data
Yang Yang	Supervisor	less than a year	no data	no data
Pu Wang	Independent Director	24.2yrs	CN¥150.00k	no data
Zong Zhen Yu	Director	less than a year	no data	0.000050% CN¥ 2.0k

2.7yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 600227's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Guizhou ChitianhuaLtd Management

Management criteria checks 2/4

Key information

Recent management updates

Guizhou Chitianhua Co.,Ltd., Annual General Meeting, May 17, 2024

Guizhou Chitianhua Co.,Ltd., Annual General Meeting, May 17, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 18%

Third quarter 2024 earnings released: EPS: CN¥0.001 (vs CN¥0.052 loss in 3Q 2023)

Guizhou Chitianhua Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Second quarter 2024 earnings released: EPS: CN¥0.002 (vs CN¥0.073 loss in 2Q 2023)

New minor risk - Share price stability

Guizhou Chitianhua Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 20% undervalued after recent price drop

Guizhou Chitianhua Co.,Ltd., Annual General Meeting, May 17, 2024

First quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.02 loss in 1Q 2023)

Guizhou Chitianhua Co.,Ltd., Annual General Meeting, May 17, 2024

Guizhou Chitianhua Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Guizhou Chitianhua Co.,Ltd. (SHSE:600227) announces an Equity Buyback for CNY 30 million worth of its shares.

Guizhou Chitianhua Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: CN¥0.052 loss per share (vs CN¥0.075 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.073 loss per share (vs CN¥0.005 loss in 2Q 2022)

Guizhou Chitianhua Co.,Ltd. to Report First Half, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.051 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.075 loss per share (vs CN¥0.022 profit in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.005 loss per share (vs CN¥0.03 profit in 2Q 2021)

Full year 2021 earnings released: CN¥0.031 loss per share (vs CN¥0.033 profit in FY 2020)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS CN¥0.022 (vs CN¥0.016 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.024 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.018 (vs CN¥0.016 loss in 1Q 2020)

New 90-day high: CN¥3.02

New 90-day low: CN¥2.58

New 90-day low: CN¥2.76

New 90-day high - CN¥2.99

First half earnings released

Guizhou Salvage Pharmaceutical Co.,Ltd. to Report First Half, 2020 Results on Aug 21, 2020

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age